Naloxone Market, By Drug Type (Branded And Generic), By Administration (Intranasal Administration, I

Published Date: | Report Code : HC2067713


Naloxone Market, By Drug Type (Branded And Generic), By Administration (Intranasal Administration, Intramuscular Administration, And Intravenous Administration), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, And Online Pharmacies), By Region (North America, Europe, Asia Pacific, Middle East & Africa, And South America) – Market Size & Forecasting To 2028

COVID-19 Impact : Our team has been closely monitoring the current developments to identify the potential impact of COVID-19 on stakeholders and business processes across the value chain of industries. A special section about COVID-19 will be covered with the report to help companies in defining sustainable strategies.

Domain : Healthcare

Report Code : HC2067713

Status : Upcoming

The Naloxone Market report points out national and global business prospects and competitive conditions for naloxone. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for naloxone. The naloxone market has been segmented by drug type (branded and generic), by administration (intranasal administration, intramuscular administration, and intravenous administration), by distribution channel (hospitals pharmacies, retail pharmacies, and online pharmacies). Historical background for the demand of naloxone has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand naloxone have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Drug Type:   

  • Lateral Flow Based Assays
  • Enzyme Label
  • Microfluidics
  • Biochips
  • Biosensors
  • Others

By Administration:

  • Diagnostic and Monitoring
  • Drug Development
  • Quality Testing

By Distribution Channel:

  • Hospitals, Clinics
  • Laboratories
  • Home Care Settings
  • Others

By Region:

North America Naloxone Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Drug Type
  • North America, by Administration
  • North America, by Distribution Channel

Europe Naloxone Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Drug Type
  • Europe, by Administration
  • Europe, by Distribution Channel

Asia Pacific Naloxone Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Drug Type
  • Asia Pacific, by Administration
  • Asia Pacific, by Distribution Channel

Middle East & Africa Naloxone Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Drug Type
  • Middle East & Africa, by Administration
  • Middle East & Africa, by Distribution Channel

South America Naloxone Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Drug Type
  • South America, by Administration
  • South America, by Distribution Channel

Major Companies: Mylan N.V., Novartis AG, Indivior Plc., ADAPT Pharma, Inc., Amphastar Pharmaceuticals, Inc., INSYS Therapeutics, Inc., Mundipharma International Limited, Kaleo, Inc., and Kern Pharma, S.L.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for naloxone market on regional and global basis.
  • To identify major segments in naloxone market and evaluate their market shares and demand.
  • To provide a competitive scenario for the naloxone market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of naloxone market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the naloxone market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the naloxone


This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales[email protected]

License Offering

Single User (PDF)


Multi User (PDF)


Enterprise User (PDF)


Get Regional Report @ USD 2000 Only

Your personal details are secure. Privacy Policy

Buy Chapters of Sections

Avail customized purchase options to meet your exact research needs.

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities
Detailed Coverage

Detailed scope covering all the major segments in the market

Meticulous Data Validations

In line data validations to ensure data precision


Market recommendations supporting decision making processes

Analyst Support

Round the clock analyst support to resolve your queries

Free Customization

Up to 15% additional free customization to meet your specific requirements

15% Free Customization

Share your Requirements

Questions?  Speak to an Analyst

Your personal details are secure. Privacy Policy